Butterfly Network (NYSE:BFLY) is a medical technology company focused on democratizing access to diagnostic imaging through its proprietary ultrasound-on-chip platform. The company’s flagship device, the Butterfly iQ, leverages semiconductor technology to deliver whole-body ultrasound imaging in a handheld form factor. This portable system connects to a compatible smart device, enabling point-of-care scanning across a variety of clinical settings.
Beyond its hardware offering, Butterfly Network provides a cloud-based software suite that supports image storage, analysis and remote collaboration. The platform includes advanced visualization tools, machine learning–driven image interpretation and telehealth capabilities, allowing healthcare professionals to share scans with specialists in real time. Subscription-based access to these digital services further expands the utility of Butterfly’s devices in both routine and specialized medical environments.
Founded in 2011 and headquartered in Guilford, Connecticut, Butterfly Network has grown its commercial footprint to serve hospitals, outpatient centers, mobile clinics and academic institutions across North America, Europe and select markets in Asia-Pacific. The company has engaged in strategic partnerships with healthcare providers and research organizations to validate clinical workflows and expand the adoption of point-of-care ultrasound diagnostics.
Under the leadership of Chief Executive Officer Todd Fruchterman, Butterfly Network has pursued regulatory clearances and broadened its product pipeline to address cardiology, musculoskeletal and vascular imaging applications. The company remains committed to innovation in medical imaging hardware and software, aiming to make diagnostic ultrasound more affordable, accessible and easy to use around the world.
